Clera home
·Dashboard

Jobs at Nurix Therapeutics (Now Hiring) — 8 open

Nurix Therapeutics logoNurix Therapeutics

Scientist I – Cell Screening and Pharmacology, Discovery Technology

Brisbane, California, United States · On-site

$127k–$143k/yr

Senior$796M raised

Scientist I – Cell Screening and Pharmacology, Discovery Technology Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degrad…

Skills: In vitro pharmacology, Cell screening, Degrader antibody conjugates, Mammalian cell culture, Assay development

Nurix Therapeutics logoNurix Therapeutics

Senior Recruiter (Contract)

Brisbane, California, United States · On-site

Senior$796M raised

Senior Recruiter (Contract) Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in in…

Skills: Full-cycle Recruiting, Sourcing, Candidate Experience, Talent Pipeline Building, Stakeholder Management

Nurix Therapeutics logoNurix Therapeutics

Senior Vice President, Preclinical Toxicology

Brisbane, California, United States · On-site

$360k–$420k/yr

Senior+$796M raised

Senior Vice President, Preclinical Toxicology Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the n…

Skills: Preclinical Toxicology, Safety Pharmacology, Drug Development, Regulatory Submissions, CRO Management

Nurix Therapeutics logoNurix Therapeutics

Senior Scientist, Antibody Conjugation

Brisbane, California, United States · On-site

$155k–$180k/yr

Senior+$796M raised

About the Role We are growing the team with a hands-on antibody conjugation scientist who will build this capability from the ground up by developing and validating bioconjugation chemistries that are reproducible at ben…

Skills: Antibody Conjugation, Bioconjugation Chemistry, FPLC/AKTA, TFF, Click Chemistry

Nurix Therapeutics logoNurix Therapeutics

Vice President, Translational Medicine & Clinical Biomarkers

Brisbane, California, United States · On-site

$332k–$378k/yr

Senior+$796M raised

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed a…

Skills: Translational Medicine Strategy, Clinical Biomarker Development, Oncology, Immunology, Targeted Protein Degradation

Nurix Therapeutics logoNurix Therapeutics

Director, Pharmaceutical Development

Brisbane, California, United States · On-site

$218k–$260k/yr

Senior+$796M raised

Title: Director, Pharmaceutical Development Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the nex…

Skills: Pharmaceutical Development, QbD Methodologies, CDMO Management, Small Molecule Drug Product Development, CMC Regulatory Submissions

Nurix Therapeutics logoNurix Therapeutics

Vice President, Global and US Market Access

Brisbane, California, United States · On-site

$325k–$365k/yr

Senior+$796M raised

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed a…

Skills: Market Access Strategy, Pricing Architecture, Payer Engagement, Contracting Strategies, Trade and Channel Management

Nurix Therapeutics logoNurix Therapeutics

Senior Manager, Regulatory Operations

Brisbane, California, United States · On-site

$140k–$162k/yr

Senior$796M raised

Company: Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approac…

Skills: Regulatory Operations, Veeva RIMS, Regulatory Submissions, eCTD, Publishing

Nurix Therapeutics logo

Scientist I – Cell Screening and Pharmacology, Discovery Technology

Nurix Therapeutics

Brisbane, California, United States • On-site

Apply
Senior

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

  • $127k–$143k/yr
  • Full-time
  • postgraduate degree, bachelor degree
  • Posted 2d ago
  • ~40 hrs/week

Responsibilities

The scientist will design, optimize, and execute an in vitro pharmacology assay cascade to characterize Degrader Antibody Conjugates (DACs). They will collaborate across multidisciplinary teams to advance drug candidates from primary screening through mechanistic pharmacological characterization.

Requirements

Candidates must hold a Ph.D. in a relevant scientific field or an MS with at least 6 years of industry experience. Strong expertise in mammalian cell culture and the design of quantitative cellular assays is required.

Full job description

Scientist I – Cell Screening and Pharmacology, Discovery Technology

 

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix’s dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine’s next chapter with a new script to outmatch disease.

Position

We are growing our DAC research team with a hands-on in vitro screening and pharmacology scientist who will help build and shape the screening and pharmacological characterization capability for Degrader Antibody Conjugates (DACs). Our DAC platform pairs antibody-based targeting with our degrader expertise to direct protein degradation to specific cell types, and this scientist will play a central role in defining how candidate molecules move through the in vitro assay cascade - from primary screening through mechanistic pharmacological characterization.

This is a lab-based role for someone who wants to bring their own expertise in designing and running in vitro pharmacology studies into an established, highly collaborative discovery organization. The scientist will design, execute, and analyze cellular assays that characterize DAC activity, and will partner closely with discovery biology, conjugation chemistry, analytical biochemistry, DMPK, and automation to advance candidates from early screening. The ideal candidate will be self-driven, resourceful, and organized, and will enjoy shaping assay strategy in a dynamic team environment.

Responsibilities

  • Design, build, and optimize the in vitro pharmacology assay cascade for DACs and biologics, from primary screening through mechanistic and quantitative characterization.
  • Develop and perform cell-based assays to characterize DAC and biologic activity, including antigen binding, target engagement, and targeted protein degradation, using cutting-edge technologies and automated workflows.
  • Cultivate and maintain mammalian cell lines (experience manipulating cell surface antigens and engineering reporter lines used to characterize DACs is preferred).
  • Collaborate with team members to contribute to the design and execution of pharmacology studies to assess the biological activity and mechanism of action of lead molecules and drug candidates.
  • Stay current with the latest scientific literature and industry developments in the fields of ADCs, DACs, biologics, and targeted protein degradation.
  • Analyze, interpret, and clearly communicate results; present findings at internal meetings and contribute to scientific discussions that drive project advancement.

Qualifications

  • D. in a relevant scientific field (Biochemistry, Pharmacology, Biology, etc.) with a strong academic track record, or MS with 6 or more years of relevant industry experience.
  • Demonstrated experience designing and setting up in vitro pharmacology studies and screening cascades; prior know-how in building screening/assay cascades in the ADC or DAC field is preferred.
  • Hands-on experience with mammalian cell culture and the ability to independently execute, analyze, and report results of quantitative cellular assays relevant to conjugate characterization (e.g., luminescence-based degradation, viability, or internalization assays).
  • Experience with mechanistic assays that dissect DAC activity, such as antibody binding and intracellular drug release, is highly desired.
  • Familiarity with automation equipment (e.g., liquid handlers) and automated workflows.
  • Strong analytical and problem-solving skills, with sound judgment in evaluating and interpreting experimental

Nurix Culture and Values 

  • Strong team orientation; highly collaborative
  • Solutions and results-oriented focus
  • Hands-on approach; resourceful and open to diverse points of view

Salary Range: $127K - 143K

Location: Brisbane, CA (Onsite role) 

Nurix Therapeutics, Inc. is committed to protecting and respecting your privacy and personal information, including information collected by Nurix when you apply for a job with Nurix or in the course of your employment with Nurix.  By applying for a position at Nurix, you agree to our collection and use of personal information as described in our Privacy Policy (https://www.nurixtx.com/privacy-policy/). 

Related keywords

DACADCBiopharmaceuticalTargeted protein degradationDrug discoveryPharmacologyIn vitroCell cultureAutomationLiquid handlersBiologicsAssay cascadeProtein degradationMechanistic characterizationAntigen bindingTarget engagement

About Nurix Therapeutics

LinkedInVisit site

Nurix is writing medicine’s next chapter using targeted protein degradation as a new script to outmatch disease.

Industry
Biotechnology
Company size
201-500 employees
Founded
2012
Headquarters
Brisbane, California
LinkedIn followers
25,748
Total funding
$796M

Important Notice to Candidates: Nurix representatives with never conduct interviews by text and will never request personal financial information or ask candidates to purchase equipment. At Nurix Therapeutics, we aim to fundamentally change the way disease is treated using degrader-based medicines. Our journey began with a vision to harness the power of the cell’s natural protein degradation machinery, the ubiquitin-proteasome system, to create a new class of therapeutics that can overcome the limitations of current treatments.

Offices: 1600 Sierra Point Pkwy, Brisbane, California 94005, US · 8800 Technology Forest Pl, Building 100, Suite 200, The Woodlands, Texas 77381, US

researchlife sciencesand biotechnologyHealth CareBiotechnologyLife ScienceTherapeutics
View all jobs at Nurix Therapeutics

About Nurix Therapeutics

LinkedInVisit site

Nurix is writing medicine’s next chapter using targeted protein degradation as a new script to outmatch disease.

Industry
Biotechnology
Company size
201-500 employees
Founded
2012
Headquarters
Brisbane, California
LinkedIn followers
25,748
Total funding
$796M

Important Notice to Candidates: Nurix representatives with never conduct interviews by text and will never request personal financial information or ask candidates to purchase equipment. At Nurix Therapeutics, we aim to fundamentally change the way disease is treated using degrader-based medicines. Our journey began with a vision to harness the power of the cell’s natural protein degradation machinery, the ubiquitin-proteasome system, to create a new class of therapeutics that can overcome the limitations of current treatments.

Offices: 1600 Sierra Point Pkwy, Brisbane, California 94005, US · 8800 Technology Forest Pl, Building 100, Suite 200, The Woodlands, Texas 77381, US

researchlife sciencesand biotechnologyHealth CareBiotechnologyLife ScienceTherapeutics
View all jobs at Nurix Therapeutics

Similar companies hiring

Regeneron (361)Prism.bio (209)Acrotech Biopharma Inc (66)Travere Therapeutics (51)Hamilton Company (51)Xencor (17)Beeflow (15)CARSO (15)ProFarm (11)Avalo Therapeutics (10)Beta Bionics (10)Jungbunzlauer (9)
Clera home

Your AI-talent agent. Connecting talents with dream jobs.

Earn $5,000

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Case Studies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Case Studies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

© 2026 Clera Labs, Inc.

PrivacyTermsBug Bounty